Form 4: Elevance Health Director Receives Stock Grant
Statement of Changes in Beneficial Ownership
Director Antonio F. Neri acquired 563 deferred stock units as part of the Elevance Health Board of Directors Compensation Program.
Summary
- Director Antonio F. Neri was granted 563 deferred stock units on May 13, 2026.
- The grant was issued under the Elevance Health, Inc. Board of Directors Compensation Program.
- Following this transaction, the director's total beneficial ownership of common stock increased to 5,488 shares.
- The units are payable in common stock upon the director's departure from the board or five years from the grant date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
The deferred stock units are scheduled to vest and be payable in common stock either five years from the grant date or upon the director's cessation of service on the board, subject to specific election terms.
Industry Context
StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the healthcare sector to ensure long-term alignment between leadership and shareholders.
Comparison to Industry Standards
- The use of deferred stock units for director compensation is consistent with standard practices among large-cap healthcare companies like UnitedHealth Group and Cigna.
- The grant size is typical for non-employee director compensation packages in the managed care industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Issuance of deferred stock units under the Board of Directors Compensation Program. | 2026-05-13 | Standard alignment of director incentives. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation practices.
Next Steps
- The director will hold the units until the earlier of five years or departure from the board.
Key Dates
| Date | Description |
|---|---|
| 2026-05-13 | Date of the deferred stock unit grant transaction. |
| 2026-05-15 | Date of filing for the Form 4 statement. |
Keywords
Elevance Health, ELV, Form 4, Insider Transaction, Director Compensation, Stock Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.